![Daniel R. Orlando](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Daniel R. Orlando
Directeur Général chez Alcresta Therapeutics, Inc.
Profil
Daniel R.
Orlando is currently the Chairman & Chief Executive Officer at Alcresta Therapeutics, Inc. Prior to this, he was the Chief Operating Officer at Vericel Corp.
from 2012 to 2019 and the Vice President-Business Development at Takeda Pharmaceuticals U.S.A., Inc. from 1999 to 2012.
He holds an MBA from Florida Atlantic University and an undergraduate degree from the University of Florida.
Postes actifs de Daniel R. Orlando
Sociétés | Poste | Début |
---|---|---|
Alcresta Therapeutics, Inc.
![]() Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Alcresta Therapeutics, Inc. engages in the development of enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases. It offers products designed to improve the delivery, digestion, and absorption of long-chain polyunsaturated fatty acids or LCPUFAs. The company was founded by Robert Gallotto and Dr. Alexey L. Margolin in 2011 and is headquartered in Newton, MA. | Directeur Général | 17/06/2019 |
Anciens postes connus de Daniel R. Orlando
Sociétés | Poste | Fin |
---|---|---|
VERICEL CORPORATION | Directeur des opérations | 14/06/2019 |
Takeda Pharmaceuticals U.S.A., Inc.
![]() Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | 01/03/2012 |
Formation de Daniel R. Orlando
Florida Atlantic University | Masters Business Admin |
University of Florida | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
VERICEL CORPORATION | Health Technology |
Entreprise privées | 2 |
---|---|
Takeda Pharmaceuticals U.S.A., Inc.
![]() Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Health Technology |
Alcresta Therapeutics, Inc.
![]() Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Alcresta Therapeutics, Inc. engages in the development of enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases. It offers products designed to improve the delivery, digestion, and absorption of long-chain polyunsaturated fatty acids or LCPUFAs. The company was founded by Robert Gallotto and Dr. Alexey L. Margolin in 2011 and is headquartered in Newton, MA. | Health Technology |